Exagen Inc. XGN Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s common stock, shares, outstanding?
- Exagen Inc. (XGN) reported common stock, shares, outstanding of $24.09M in Q1 2026.
- How has Exagen Inc.'s common stock, shares, outstanding changed year-over-year?
- Exagen Inc.'s common stock, shares, outstanding increased by 34.2% year-over-year, from $17.95M to $24.09M.
- What is the long-term trend for Exagen Inc.'s common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Exagen Inc.'s common stock, shares, outstanding has grown at a 12.6% compound annual growth rate (CAGR), from $12.65M to $22.91M.